Evidence map›Paper›PMID 36353184›Full record

ArticleBMJ surgery, interventions, & health technologies2022

Assessing the development status of intraoperative fluorescence imaging for anatomy visualisation, using the IDEAL framework.

Takeaki Ishizawa, Peter McCulloch, Laurents Stassen, Jacqueline van den Bos, Jean-Marc Regimbeau, Jeanne Dembinski, Sylke Schneider-Koriath, Luigi Boni, Takeshi Aoki, Hiroto Nishino and 12 more

Open access · goldAbstract read
In one paragraph

Article in BMJ surgery, interventions, & health technologies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 18 institutions in 9 countries.

Takeaki IshizawaDepartment of Hepatobiliary-Pancreatic Surgery, Osaka Metropolitan University, Osaka, Japan.
Peter McCullochIDEAL Collaboration, Nuffield Department of Surgical Science, University of Oxford, Oxford, Oxfordshire, UK.ORCID 0000-0002-3210-8273
Laurents StassenDepartment of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
Jacqueline van den BosDepartment of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
Jean-Marc RegimbeauDepartment of Digestive Surgery, Simplification of Surgical Patient Care research unit, Amiens University Hospital and University of Picardie, Amiens, France.
Jeanne DembinskiDepartment of Digestive Surgery, Simplification of Surgical Patient Care research unit, Amiens University Hospital and University of Picardie, Amiens, France.
Sylke Schneider-KoriathVisceral Surgery, Klinikum Südstadt Rostock, Rostock, Mecklenburg-Vorpommern, Germany.
Luigi BoniDepartment of Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy.
Takeshi AokiDivision of Gastroenterological and General Surgery, Department of Surgery, School of Medicine, Showa University, Tokyo, Japan.
Hiroto NishinoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kiyoshi HasegawaHepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan.
Yasuo SekineDepartment of Thoracic Surgery, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Toyofumi Chen-YoshikawaDepartment of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Trevor YeungNuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Eren BerberDepartment of Endocrine and General Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Bora KahramangilCleveland Clinic Florida, Weston, Florida, USA.
Michael BouvetUniversity of California San Diego, La Jolla, California, USA.
Michele DianaInstitute of Image-Guided Surgery and IRCAD, Research Institute against Cancer of the Digestive System, IHU Strasbourg, Strasbourg, France.
Norihiro KokudoNational Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Fernando DipCleveland Clinic Florida, Weston, Florida, USA.
Kevin WhiteScience Right Research Consulting London, London, Ontario, Canada.
Raul J RosenthalCleveland Clinic Florida, Weston, Florida, USA.
Centre Hospitalier Universitaire Amiens-Picardie · FRCleveland Clinic Florida · USMaastricht University · NLCleveland Clinic · USFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITInstitut de Recherche contre les Cancers de l’Appareil Digestif · FRKlinikum Südstadt Rostock · DEKyoto University · JPNagoya University · JPNational Center for Global Health and Medicine · JPOsaka Metropolitan University · JPPeter MacCallum Cancer Centre · AUShowa University · JPThe University of Tokyo · JPTokyo Women's Medical University · JPUniversidad de Buenos Aires · ARUniversity of California San Diego · USUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Intraoperative fluorescence imaging is currently used in a variety of surgical fields for four main purposes: visualising anatomy, assessing tissue perfusion, identifying/localising cancer and mapping lymphatic systems. To establish evidence-based guidance for research and practice, understanding the state of research on fluorescence imaging in different surgical fields is needed. We evaluated the evidence on fluorescence imaging used to visualise anatomical structures using the IDEAL framework, a framework designed to describe the stages of innovation in surgery and other interventional procedures. Design: IDEAL staging based on a thorough literature review. Setting: All publications on intraoperative fluorescence imaging for visualising anatomical structures reported in PubMed through 2020 were identified for five surgical procedures: cholangiography, hepatic segmentation, lung segmentation, ureterography and parathyroid identification. Main outcome measures: The IDEAL stage of research evidence was determined for each of the five procedures using a previously described approach. Results: 225 articles (8427 cases) were selected for analysis. Current status of research evidence on fluorescence imaging was rated IDEAL stage 2a for ureterography and lung segmentation, IDEAL 2b for hepatic segmentation and IDEAL stage 3 for cholangiography and parathyroid identification. Enhanced tissue identification rates using fluorescence imaging relative to conventional white-light imaging have been documented for all five procedures by comparative studies including randomised controlled trials for cholangiography and parathyroid identification. Advantages of anatomy visualisation with fluorescence imaging for improving short-term and long-term postoperative outcomes also were demonstrated, especially for hepatobiliary surgery and (para)thyroidectomy. No adverse reactions associated with fluorescent agents were reported. Conclusions: Intraoperative fluorescence imaging can be used safely to enhance the identification of anatomical structures, which may lead to improved postoperative outcomes. Overviewing current research knowledge using the IDEAL framework aids in designing further studies to develop fluorescence imaging techniques into an essential intraoperative navigation tool in each surgical field.

Indexed as

ConsensusLaparoscopyTechnologyThoracoscopy

Identifiers

PMID36353184
PMCPMC9639126
OpenAlexW4308210061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.